Literature DB >> 3130631

Roles for chloride ion and fibrinogen in the activation of [Glu1]plasminogen in human plasma.

P J Gaffney1, T Urano, V S de Serrano, M Mahmoud-Alexandroni, A R Metzger, F J Castellino.   

Abstract

Using two-dimensional immunoelectrophoresis and an antibody to alpha 2-antiplasmin, we assessed the plasmin generated in serum under different conditions as the plasmin-alpha 2-antiplasmin complex. Activation in serum of human [Glu1]plasminogen ([Glu1]Pg) by recombinant tissue plasminogen activator was inhibited by the normal serum levels of Cl- and was enhanced by physiological levels of fibrinogen in the presence or absence of Cl-. These results agree with the recognized ability of Cl- to induce a conformation in [Glu1]Pg less favorable for its activation than the conformation that results without Cl-. The enhancing effect of fibrinogen surpassed the inhibitory effect of Cl- over a wide range of recombinant tissue plasminogen activator concentrations in physiological serum. Lesser inhibition by Cl- was seen in a purified clot-lysis system, suggesting that [Glu1]Pg conformation when attached to soluble fibrin matrix was less affected by the anion. The data regarding the roles of circulating fibrinogen and Cl- in controlling the plasma level of activated [Glu1]Pg have important implications in thrombolytic therapy with recombinant tissue plasminogen activator.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3130631      PMCID: PMC280260          DOI: 10.1073/pnas.85.10.3595

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Soluble high-molecular-weight E fragments in the plasmin-induced degradation products of cross-linked human fibrin.

Authors:  P J Gaffney; D A Lane; M Brasher
Journal:  Clin Sci Mol Med       Date:  1975-08

2.  Measurement of the binding of antifibrinolytic amino acids to various plasminogens.

Authors:  W J Brockway; F J Castellino
Journal:  Arch Biochem Biophys       Date:  1972-07       Impact factor: 4.013

3.  The effect of alpha-,omega-amino acids on human plasminogen structure and activation.

Authors:  B N Violand; R Byrne; F J Castellino
Journal:  J Biol Chem       Date:  1978-08-10       Impact factor: 5.157

Review 4.  On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.

Authors:  D Collen
Journal:  Thromb Haemost       Date:  1980-06-18       Impact factor: 5.249

5.  Properties of three different molecular forms of the alpha 2 plasmin inhibitor.

Authors:  I Clemmensen; S Thorsen; S Müllertz; L C Petersen
Journal:  Eur J Biochem       Date:  1981-11

6.  Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids.

Authors:  S Thorsen
Journal:  Biochim Biophys Acta       Date:  1975-05-30

7.  Effects of human fibrinogen and its cleavage products on activation of human plasminogen by streptokinase.

Authors:  B A Chibber; J P Morris; F J Castellino
Journal:  Biochemistry       Date:  1985-07-02       Impact factor: 3.162

8.  Influence of exogenous and endogenous tissue-type plasminogen activator on the lysability of clots in a plasma milieu in vitro.

Authors:  C Zamarron; H R Lijnen; D Collen
Journal:  Thromb Res       Date:  1984-08-01       Impact factor: 3.944

9.  Rapid formation of an anion-sensitive active site in stoichiometric complexes of streptokinase and human [Glu1]plasminogen.

Authors:  B A Chibber; J T Radek; J P Morris; F J Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  Reaction of tissue-type plasminogen activator with 4-methylumbelliferyl-p-guanidinobenzoate hydrochloride.

Authors:  T Urano; S Urano; F J Castellino
Journal:  Biochem Biophys Res Commun       Date:  1988-01-15       Impact factor: 3.575

View more
  2 in total

1.  Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.

Authors:  S Urano; A R Metzger; F J Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 2.  Tissue plasminogen activator for thrombolytic therapy: expectation versus reality.

Authors:  P J Gaffney
Journal:  J R Soc Med       Date:  1992-11       Impact factor: 18.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.